OS Therapies Incorporated
OSTX
$2.00
$0.189.89%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.88M | -7.36M | -6.46M | -7.40M | -7.79M |
| Total Depreciation and Amortization | 2.80K | 1.40K | 4.70K | 4.80K | 4.20K |
| Total Amortization of Deferred Charges | 1.43M | 1.64M | 2.28M | 2.61M | 2.65M |
| Total Other Non-Cash Items | 301.80K | 0.00 | 0.00 | 0.00 | 116.70K |
| Change in Net Operating Assets | -129.80K | -63.00K | 898.90K | 1.57M | 2.02M |
| Cash from Operations | -7.28M | -5.78M | -3.27M | -3.22M | -3.01M |
| Capital Expenditure | -- | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.00 | 0.00 | 0.00 | 1.10K |
| Cash from Investing | -- | 0.00 | 0.00 | 0.00 | 1.10K |
| Total Debt Issued | 1.75M | 2.82M | 3.65M | 3.23M | 3.16M |
| Total Debt Repaid | -250.00K | -250.00K | -- | -- | -- |
| Issuance of Common Stock | 5.23M | 5.23M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 6.05M | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -175.90K | -329.60K | -267.90K | -284.10K |
| Cash from Financing | 12.78M | 7.62M | 3.32M | 2.97M | 2.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.49M | 1.84M | 45.60K | -255.10K | -132.60K |